Absci Corporation (ABSI)
NASDAQ: ABSI · Real-Time Price · USD
3.900
+0.240 (6.56%)
At close: Oct 14, 2025, 4:00 PM EDT
3.930
+0.030 (0.77%)
After-hours: Oct 14, 2025, 7:57 PM EDT
Absci Revenue
Absci had revenue of $593.00K in the quarter ending June 30, 2025, a decrease of -53.31%. This brings the company's revenue in the last twelve months to $4.14M, up 27.32% year-over-year. In the year 2024, Absci had annual revenue of $4.53M, down -20.71%.
Revenue (ttm)
$4.14M
Revenue Growth
+27.32%
P/S Ratio
113.27
Revenue / Employee
$26,357
Employees
157
Market Cap
583.14M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.53M | -1.18M | -20.71% |
| Dec 31, 2023 | 5.72M | -29.00K | -0.50% |
| Dec 31, 2022 | 5.75M | 965.00K | 20.18% |
| Dec 31, 2021 | 4.78M | 2.00K | 0.04% |
| Dec 31, 2020 | 4.78M | 2.72M | 132.04% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
ABSI News
- 4 weeks ago - Absci Boosts AI-Powered Drug Discovery With Oracle And AMD Collaboration - Benzinga
- 4 weeks ago - Absci Accelerates AI-Driven Drug Discovery with Oracle and AMD - GlobeNewsWire
- 5 weeks ago - Absci Corporation (ABSI) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 7 weeks ago - Absci Expands ABS-201 Scientific Advisory Board with Addition of Leading Dermatology Experts Dr. Rodney Sinclair and Dr. David Goldberg - GlobeNewsWire
- 7 weeks ago - Absci to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Absci Corporation (ABSI) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Absci Reports Business Updates and Second Quarter 2025 Financial and Operating Results - GlobeNewsWire
- 2 months ago - Almirall and Absci Expand AI Drug Creation Collaboration Adding a Second Dermatology Target - GlobeNewsWire